Ocera Therapeutics, Inc. of Palo Alto, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-06-24. The offering totals $3.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 27 people.
| Name | Role | Location |
|---|---|---|
| Jean-Paul K Castaigne | Director | Durham, NC |
| Donald F Corcoran | Director | Durham, NC |
| Aaron F Davidson | Director | Durham, NC |
| DAVID J DRUTZ | Director | MONTREAL, A8 |
| Vipin K Garg | Director | Durham, NC |
| Brenda D Gavin | Director | Philadelphia, PA |
| Alex D Zisson | Director | Stamford, CT |
| Richard I Eisenstadt | Executive Officer | Durham, NC |
| Vipin K Garg | Executive Officer | Durham, NC |
| Nina S Kjellson | Director | Palo Alto, CA |
| Eckard F Weber | Director | Palo Alto, CA |
| Nina L Kjellson | Director | Palo Alto, CA |
| Pratik F Shah | Director | Palo Alto, CA |
| Franck S Rousseau | Director | Palo Alto, CA |
| Franck S Rousseau | Executive Officer | Palo Alto, CA |
| Jeryl L Hilleman | Executive Officer | Palo Alto, CA |
| Jean-Paul G Castaigne | Director | Palo Alto, CA |
| David S Moore | Executive Officer | Palo Alto, CA |
| Lars G Ekman | Director | Palo Alto, CA |
| Linda S Grais | Director | Palo Alto, CA |
| Linda S Grais | Executive Officer | Palo Alto, CA |
| Anne M VanLent | Director | Palo Alto, CA |
| Anne M VanLent | Executive Officer | Palo Alto, CA |
| Michael F Powell | Director | Palo Alto, CA |
| Lars F Ekman | Director | San Diego, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2013-11-21 | D | $28.0M | $28.0M |
| 2013-07-24 | D | — | — |
| 2013-07-16 | D | — | $20.0M |
| 2013-07-16 | D | — | — |
| 2013-07-16 | D/A | — | — |